Indefinite Delivery Contract 36C26126D0032
Award Date 4/26/26
Last Date to Order 4/25/31
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Pricing Type
Firm Fixed Price
Legislative Mandate
Employment Eligibility Verification
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed Similar IDVs
- Neogenomics Laboratories, Inc., a Fort Myers, Florida-based cancer diagnostics laboratory, was awarded a single-award Indefinite Delivery Contract valued at $5,000,000 by Veterans Integrated Service Network 21 (VISN 21) of the Department of Veterans Affairs on April 26, 2021, with an ultimate completion date of April 25, 2026. The contract procures off-site anatomic pathology laboratory services to support the VA Palo Alto Health Care System and VA Central California Health Care System. Services...
- The Department of Veterans Affairs Veterans Integrated Service Network 17 awarded a single-award Indefinite Delivery Contract valued at $16.0 million to Neogenomics Laboratories, Inc., effective January 21, 2023, through December 31, 2027. Neogenomics Laboratories, a for-profit cancer diagnostics laboratory headquartered in Fort Myers, Florida, will provide specialized reference laboratory testing services to support diagnostic and treatment capabilities across the VA healthcare system. The...
- Neogenomics Laboratories, Inc., a for-profit cancer diagnostics laboratory, holds multiple Indefinite Delivery Vehicles (IDVs) and Blanket Purchase Agreements (BPAs) with the Department of Veterans Affairs (VA) and Indian Health Service to provide specialized reference laboratory testing services. Under these contract vehicles, Neogenomics delivers a range of diagnostic testing, including fluorescence in situ hybridization (FISH), genomic sequencing, flow cytometry, cytogenetic analysis, and...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19 awarded Neogenomics Laboratories, Inc. a blanket purchase agreement to provide immunohistochemical genetic testing and staining services in support of the Rocky Mountain Regional VA Medical Center. Over five consecutive one-year ordering periods from July 2020 through June 2025, call orders valued from $38,758 to $90,000 have been placed against this agreement to procure these diagnostic...
- This Blanket Purchase Agreement (BPA) was awarded by the Department of Veterans Affairs (VA) Veterans Integrated Service Network 19 to Neogenomics Laboratories, Inc., a for-profit cancer diagnostics laboratory based in Fort Myers, Florida. The contract, valued at up to $659,350.80, covers a period of performance from July 1, 2025 to June 30, 2030. The BPA is intended to procure a wide range of specialized reference laboratory testing services to support the VA's healthcare diagnosis and...
- This Blanket Purchase Agreement (BPA) was awarded by the Veterans Integrated Service Network 8, a component of the Department of Veterans Affairs (VA), to Neogenomics Laboratories, Inc., a for-profit cancer diagnostics laboratory. The $75,000 single-award BPA has a 5-year period of performance through September 2026 and is for the provision of specialized reference laboratory testing services, including genomic sequencing, flow cytometry, cytogenetic analysis, and other advanced diagnostic and...
- Veterans Integrated Service Network 1 (VISN 1) of the Department of Veterans Affairs awarded a Blanket Purchase Agreement to Neogenomics Laboratories, Inc. for the provision of fluorescence in situ hybridization (FISH) testing services. The BPA, valued at a ceiling of $3.076 million, commenced on April 1, 2024, and extends through March 31, 2029, with no set-aside designation applied. The contract utilizes a firm fixed price pricing structure and represents a single award to the Fort Myers,...
- Genomic Health, Inc., a subsidiary of Exact Sciences Corporation, holds a single-award Blanket Purchase Agreement with the Department of Veterans Affairs Veterans Integrated Service Network 22 for the provision of Oncotype genetic testing services. The contract, awarded on February 24, 2023, carries a ceiling value of $970,352 and extends through February 23, 2028. Performance occurs at Veterans Administration facilities in California (90073). The contract utilizes a firm fixed-price structure...
- The Department of the Army Medical Command has awarded Neogenomics Laboratories, Inc., a for-profit cancer diagnostics laboratory, a 5-year Blanket Purchase Agreement (BPA) to provide NEOTYPE SOLID TUMOR TESTING AND REPEAT FISH TESTING at Tripler Army Medical Center in Hawaii. The BPA has a potential value of $1,000,000.00 and covers the period from April 1, 2019 to March 11, 2024. Through this single-award IDV, Neogenomics will furnish specialized cancer testing and diagnostic services,...
- Air Mobility Command awarded a single-award Blanket Purchase Agreement valued at $513,470 to Neogenomics Laboratories, Inc. (UEI: ML9LFC5CK7K9) on February 1, 2022, with an ultimate completion date of January 31, 2024. This agreement, awarded through full and open competition with no set-aside designation, establishes a vehicle for anatomic pathology testing services to support Air Mobility Command operations and personnel. Neogenomics Laboratories, a for-profit cancer diagnostics laboratory...